Elevara Medicines

About Elevara Medicines

Elevara Medicines is a clinical-stage biotech company focused on addressing the fundamental problem in rheumatoid arthritis (RA) treatment where patients fail to achieve remission with existing immune-targeted therapies. By targeting fibroblast-like synoviocytes (FLS), the company aims to break the efficacy ceiling of current immunosuppressive drugs and improve outcomes for RA patients and beyond.

Products & Services

ELV001:A once-daily small molecule drug targeting the proliferation and inflammatory signaling of RA fibroblast-like synoviocytes (FLS). It features a non-immunosuppressive, orthogonal mechanism that synergizes with approved synthetic and biological disease-modifying anti-rheumatic drugs (DMARDs) for rapid and robust efficacy.

START-SYNERGY Trial:A global Phase 2b clinical study evaluating ELV001 as an add-on therapy for RA patients with inadequate response to standard treatments like methotrexate and TNF inhibitors. The trial aims to deliver faster relief, improved remission rates, and safer long-term options, recruiting patients from multiple countries starting December 2025.

Specialties

Rheumatoid Arthritis Treatment Synovial Fibroblast Targeting Clinical-Stage Drug Development Chronic Inflammatory Diseases

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Series A T: - FT: Series A	A: 70000000 MR: - FA: 70 million FAN: 70000000	D: 2025-10-22 FD: 2025-10-22	3 investors

Series A Latest

2025-10-22

$70.0M

3 investors (Pro only)

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

E

Emma Tinsley

CEO

P

Professor Dominique Baeten

CMO

G

Geoff Brooks

Head of Clinical Operations

K

Kirsty Wydenbach

Head of Regulatory

S

Simon Hutchings

Head of Clinical Pharmacology

M

Margaret Jones

Head of Biometrics

View 7 more team members with Pro

Unlock Full Team Directory

Recent News